Ligand Reports Third Quarter 2019 Financial Results

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and nine months ended September 30, 2019 and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions. ?We are very pleased with how the company is performing as we approach the end of the year,? said John Higgins, Chief Executive Officer o